Metraipolis › archive › dc_9aaba2e9af96

Advances in natural killer cell immunotherapy for hematologic malignancies — Europe PMC PMID:42033215

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42033215
DOI
10.1080/15384047.2026.2658896
License (as archived)
solo-consultazione
Archived
2026-11-03T05:35:44.844Z
SHA-256 of the archived text
3125668a5f728f1d4e1df8a2d371e717860ec00de5762732bccdd5732ac20084
Stable URL of this page
https://metraipolis.com/documento/dc_9aaba2e9af96

How to cite

Advances in natural killer cell immunotherapy for hematologic malignancies — Europe PMC PMID:42033215 — Europe PMC (en), https://europepmc.org/article/MED/42033215 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9aaba2e9af96 (Metraipolis archive dc_9aaba2e9af96, sha256 3125668a5f728f1d4e1df8a2d371e717860ec00de5762732bccdd5732ac20084)
BibTeX
@misc{dc9aaba2e9af96,
  title = {Advances in natural killer cell immunotherapy for hematologic malignancies — Europe PMC PMID:42033215},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42033215},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9aaba2e9af96; sha256 3125668a5f728f1d4e1df8a2d371e717860ec00de5762732bccdd5732ac20084},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42033215. Agents can read the archived copy with the MCP tool read_document.